Follow
Vidyasrilekha Yele
Vidyasrilekha Yele
Other namesVidyasrilekha Sanapalli
Assistant Professor
Verified email at nmims.edu - Homepage
Title
Cited by
Cited by
Year
Preclinical models of diabetic wound healing: A critical review
BKR Sanapalli, V Yele, MK Singh, PT Krishnamurthy, VVSR Karri
Biomedicine & Pharmacotherapy 142, 111946, 2021
252021
Synthesis, Molecular Docking and Biological Evaluation of 2‐Aryloxy‐N‐Phenylacetamide and N′‐(2‐Aryloxyoxyacetyl) Benzohydrazide Derivatives as Potential …
V Yele, MA Azam, AD Wadhwani
Chemistry & Biodiversity 18 (4), e2000907, 2021
182021
HER2 targeted biological macromolecule modified liposomes for improved efficacy of capecitabine in breast cancer
MK Singh, SKSS Pindiprolu, BKR Sanapalli, V Yele, GNK Ganesh
International journal of biological macromolecules 150, 631-636, 2020
162020
Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer: In vitro studies
MK Singh, SKSS Pindiprolu, BKR Sanapalli, V Yele, GNK Ganesh
RSC advances 9 (43), 24987-24994, 2019
152019
Human beta defensins may be a multifactorial modulator in the management of diabetic wound
BKR Sanapalli, V Yele, RSR Kalidhindi, SK Singh, M Gulati, VVSR Karri
Wound Repair and Regeneration 28 (3), 416-421, 2020
132020
Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B. 1.1. 7 (Alpha) and P. 1 (Gamma) variant spike glycoproteins: A computational approach
V Yele, BKR Sanapalli, AA Mohammed
Chemical Papers, 1-11, 2022
82022
DFT calculation, molecular docking, and molecular dynamics simulation study on substituted phenylacetamide and benzohydrazide derivatives
V Yele, DK Sigalapalli, S Jupudi, AA Mohammed
Journal of Molecular Modeling 27 (12), 359, 2021
82021
Synthesis and preclinical evaluation of indole triazole conjugates as microtubule targeting agents that are effective against MCF-7 breast cancer cell lines
V Yele, SKSS Pindiprolu, S Sana, D Ramamurty, JRK Madasi, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021
82021
Ligand-based pharmacophore modelling, in silico virtual screening, molecular docking and molecular dynamic simulation study to identify novel Francisella tularensis ParE inhibitors
V Yele, MA Azam, S Jupudi
Chemical Papers 74, 4567-4580, 2020
82020
Human beta defensin-2 loaded PLGA nanoparticles impregnated in collagen-chitosan composite scaffold for the management of diabetic wounds
BKR Sanapalli, V Yele, MK Singh, SN Thumbooru, M Parvathaneni, ...
Biomedicine & Pharmacotherapy 161, 114540, 2023
72023
Ligand-based pharmacophore modeling and molecular dynamic simulation approaches to identify putative MMP-9 inhibitors
BKR Sanapalli, V Yele, S Jupudi, VVSR Karri
RSC advances 11 (43), 26820-26831, 2021
72021
Synthetic imidazopyridine-based derivatives as potential inhibitors against multi-drug resistant bacterial infections: a review
BKR Sanapalli, A Ashames, DK Sigalapalli, AB Shaik, RR Bhandare, ...
Antibiotics 11 (12), 1680, 2022
62022
Insights into the pharmacophore-based 3D-QSAR modeling, molecular dynamics simulation studies of certain dihydroxy pyrrolidine/piperidine and aza-flavanone derivatives as α …
DK Sigalapalli, V Yele, S Jupudi, AS Shaikh, M Kadagathur, ...
Journal of Molecular Structure 1223, 129243, 2021
52021
Identification of novel protein kinase C-βII inhibitors: virtual screening, molecular docking and molecular dynamics simulation studies
BKR Sanapalli, V Yele, L Baldaniya, VVSR Karri
Journal of Molecular Modeling 28 (5), 117, 2022
42022
Synthesis and Evaluation of Aryl/Heteroaryl Benzohydrazide and Phenylacetamide Derivatives as Broad‐Spectrum Antibacterial Agents
V Yele, AA Mohammed, AD Wadhwani
ChemistrySelect 5 (34), 10581-10587, 2020
42020
Benzohydrazide and phenylacetamide scaffolds: New putative ParE inhibitors
V Yele, BKR Sanapalli, AD Wadhwani, AA Mohammed
Frontiers in Bioengineering and Biotechnology 9, 669728, 2021
32021
Filamentous temperature sensitive mutant Z: a putative target to combat antibacterial resistance
S Kifayat, V Yele, A Ashames, DK Sigalapalli, RR Bhandare, AB Shaik, ...
RSC advances 13 (17), 11368-11384, 2023
22023
Dual acting immuno-antibiotics: computational investigation on antibacterial efficacy of immune boosters against isoprenoid H enzyme
H Jamod, K Mehta, A Sakariya, S Shoukani, BKR Sanapalli, V Yele
ASSAY and Drug Development Technologies 20 (5), 225-236, 2022
22022
Possible role of rivoglitazone thiazolidine class of drug as dual-target therapeutic agent for bacterial infections: An in silico study
V Yele, N Saha, AA Md
Medical Hypotheses 131, 109305, 2019
22019
Marine drugs as putative inhibitors against non-structural proteins of SARS-CoV-2: an in silico study
S Patel, H Hasan, D Umraliya, BKR Sanapalli, V Yele
Journal of Molecular Modeling 29 (6), 176, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20